Orexin Neurons in Narcolepsy with Cataplexy

Migration, Crosslink

📗 Cite This Artifact

←

Home / Artifacts / Orexin Neurons in Narcolepsy with Cataplexy

📖

Orexin Neurons in Narcolepsy with Cataplexy

active

wiki page Created: 2026-04-02T07:19:40 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-orexin-neurons-narcoleps

📖 Wiki Page

cell1428 wordssynced 2026-04-02

Orexin Neurons in Narcolepsy with Cataplexy

Introduction

flowchart TD Orexin_Neurons_in_Narcolepsy_w["Orexin Neurons in Narcolepsy with Cataplexy"] Orexin_Neurons_in_Narcolepsy_w["Cataplexy"] Orexin_Neurons_in_Narcolepsy_w -->|"related to"| Orexin_Neurons_in_Narcolepsy_w style Orexin_Neurons_in_Narcolepsy_w fill:#81c784,stroke:#333,color:#000 Orexin_Neurons_in_Narcolepsy_w["Introduction"] Orexin_Neurons_in_Narcolepsy_w -->|"related to"| Orexin_Neurons_in_Narcolepsy_w style Orexin_Neurons_in_Narcolepsy_w fill:#81c784,stroke:#333,color:#000 Orexin_Neurons_in_Narcolepsy_w["table"] Orexin_Neurons_in_Narcolepsy_w -->|"related to"| Orexin_Neurons_in_Narcolepsy_w style Orexin_Neurons_in_Narcolepsy_w fill:#81c784,stroke:#333,color:#000 style Orexin_Neurons_in_Narcolepsy_w fill:#4fc3f7,stroke:#333,color:#000

...

Orexin Neurons in Narcolepsy with Cataplexy

Introduction

Mermaid diagram (expand to render)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Orexin Neurons in Narcolepsy with Cataplexy</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Lateral hypothalamus, perifornical region</td>
</tr>
<tr>
<td class="label">Number</td>
<td>~70,000 neurons in human brain</td>
</tr>
<tr>
<td class="label">Distribution</td>
<td>Bilateral, dorsal to fornix</td>
</tr>
<tr>
<td class="label">Size</td>
<td>Medium-sized (20-30 mum diameter)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Projection Type</td>
</tr>
<tr>
<td class="label">Locus coeruleus</td>
<td>Excitatory</td>
</tr>
<tr>
<td class="label">Dorsal raphe</td>
<td>Excitatory</td>
</tr>
<tr>
<td class="label">Tubermammillary nucleus</td>
<td>Excitatory</td>
</tr>
<tr>
<td class="label">VTA</td>
<td>Excitatory</td>
</tr>
<tr>
<td class="label">Basal forebrain</td>
<td>Excitatory</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Excitatory</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>Descending</td>
</tr>
<tr>
<td class="label">Ventrolateral preoptic area</td>
<td>Inhibitory</td>
</tr>
<tr>
<td class="label">Peptide</td>
<td>Length</td>
</tr>
<tr>
<td class="label">Orexin-A (Hypocretin-1)</td>
<td>33 amino acids</td>
</tr>
<tr>
<td class="label">Orexin-B (Hypocretin-2)</td>
<td>28 amino acids</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">OX1R</td>
<td>HCRTR1</td>
</tr>
<tr>
<td class="label">OX2R</td>
<td>HCRTR2</td>
</tr>
<tr>
<td class="label">Factor</td>
<td>Role</td>
</tr>
<tr>
<td class="label">NeuroD1</td>
<td>Differentiation</td>
</tr>
<tr>
<td class="label">Ascl1</td>
<td>Fate specification</td>
</tr>
<tr>
<td class="label">Nkx2.1</td>
<td>Regional identity</td>
</tr>
<tr>
<td class="label">Lhx9</td>
<td>Neuron specification</td>
</tr>
<tr>
<td class="label">Signal</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Glucose</td>
<td>Inhibited</td>
</tr>
<tr>
<td class="label">Leptin</td>
<td>Excited</td>
</tr>
<tr>
<td class="label">Ghrelin</td>
<td>Excited</td>
</tr>
<tr>
<td class="label">Amino acids</td>
<td>Excited</td>
</tr>
<tr>
<td class="label">Free fatty acids</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Evidence</td>
<td>Details</td>
</tr>
<tr>
<td class="label">HLA association</td>
<td>DQB1*06:02 in >95% of cases</td>
</tr>
<tr>
<td class="label">T cell activation</td>
<td>CD4+ and CD8+ orexin-reactive T cells</td>
</tr>
<tr>
<td class="label">Seasonal pattern</td>
<td>Peak onset after winter infections</td>
</tr>
<tr>
<td class="label">Streptococcal association</td>
<td>Post-infectious cases</td>
</tr>
<tr>
<td class="label">Pandemrix vaccine</td>
<td>6-13x increased risk (adjuvant effect)</td>
</tr>
<tr>
<td class="label">Autoantibodies</td>
<td>Controversial, not consistently detected</td>
</tr>
<tr>
<td class="label">Symptom</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Excessive daytime sleepiness</td>
<td>Loss of wake drive</td>
</tr>
<tr>
<td class="label">Cataplexy</td>
<td>REM atonia intrusion</td>
</tr>
<tr>
<td class="label">Sleep paralysis</td>
<td>REM atonia intrusion</td>
</tr>
<tr>
<td class="label">Hypnagogic hallucinations</td>
<td>REM imagery intrusion</td>
</tr>
<tr>
<td class="label">Fragmented sleep</td>
<td>Loss of sleep stabilization</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Indication</td>
</tr>
<tr>
<td class="label">Modafinil/armodafinil</td>
<td>EDS</td>
</tr>
<tr>
<td class="label">Sodium oxybate</td>
<td>EDS + cataplexy</td>
</tr>
<tr>
<td class="label">Venlafaxine</td>
<td>Cataplexy</td>
</tr>
<tr>
<td class="label">Clomipramine</td>
<td>Cataplexy</td>
</tr>
<tr>
<td class="label">Pitolisant</td>
<td>EDS</td>
</tr>
</table>

Orexin (hypocretin) [neurons](/entities/neurons) are a small population of hypothalamic neurons that produce the neuropeptides orexin-A and orexin-B (hypocretin-1 and -2). These neurons are the master regulators of wakefulness and arousal, and their selective destruction causes narcolepsy type 1 (NT1), characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations. The near-complete loss of orexin neurons (>90%) in NT1 represents one of the most specific and severe neurodegenerative processes in human disease, providing insights into selective neuronal vulnerability relevant to Parkinson's disease, [Alzheimer's disease](/diseases/alzheimers-disease), and other neurodegenerative conditions.[@de1998][@sakurai1998]

Neuroanatomy of Orexin Neurons

Location and Distribution

Orexin neurons are exclusively located in the lateral hypothalamus/perifornical area:

Morphology

Orexin neurons have extensive, widely projecting axons:

Multipolar morphology: Multiple primary dendrites
Extensive projections: Throughout neuroaxis
Bouton density: High terminal density in target regions
Colocalization: Some co-express dynorphin, NARP, CART

Projection Targets

Molecular Biology

Orexin Peptides

The orexin gene (HCRT) encodes prepro-orexin, which is cleaved to produce two peptides:

Orexin Receptors

Two G-protein coupled receptors mediate orexin effects:

OX2R mutations cause canine narcolepsy, highlighting its critical role in sleep regulation.[@lin1999]

Intracellular Signaling

Orexin receptor activation triggers:

Phospholipase C activation: IP3/DAG pathway
Calcium mobilization: Intracellular Ca2+ release
MAPK activation: ERK1/2 phosphorylation
[mTOR](/mechanisms/mtor-signaling-pathway) signaling: Metabolic regulation
PKC activation: Protein kinase C

Transcriptional Regulation

Physiology of Wakefulness

Wake-Sleep Switch Model

The orexin system stabilizes the wake-sleep switch:

Wake promotion: Excitatory input to wake-active nuclei
Sleep inhibition: Suppression of VLPO sleep neurons
State stabilization: Prevents inappropriate transitions
Arousal modulation: Context-dependent activation

Loss of orexin destabilizes this switch, causing inappropriate transitions between wake and sleep.[@saper2001]

Diurnal Rhythm

Orexin neuron activity follows circadian variation:

Wake-active peak: Maximum firing during active period
Sleep nadir: Minimal activity during sleep
SCN input: Circadian drive via subparaventricular zone
Light modulation: Photoperiod effects on orexin release

Metabolic Integration

Orexin neurons sense and respond to metabolic state:

This metabolic integration links feeding, arousal, and energy balance.

Narcolepsy Pathophysiology

Selective Neuron Loss

NT1 is characterized by remarkably selective orexin neuron destruction:

>90% orexin neuron loss: Confirmed in postmortem studies
Undetectable CSF orexin-A: <110 pg/mL (normal >200)
Preserved adjacent neurons: Other hypothalamic neurons spared
Gliosis: Reactive [astrocytes](/entities/astrocytes) in orexin neuron region

This selectivity suggests a specific vulnerability mechanism rather than general neurodegeneration.[@thannickal2000]

Autoimmune Hypothesis

Strong evidence supports autoimmune pathogenesis:

The HLA association is among the strongest in medicine, comparable to celiac disease.[@mignot2001]

Molecular Mimicry

Candidate triggers for molecular mimicry:

Influenza proteins: Structural similarity to orexin
Streptococcal antigens: Cross-reactive epitopes
Gut [microbiome](/entities/microbiome): Potential antigenic sources
Prepro-orexin epitopes: T cell recognition sites identified

Neuroinflammation

Evidence for inflammatory mechanisms:

Microglial activation: Observed in narcolepsy brains
Cytokine elevation: Elevated IL-6, TNF-α
T cell infiltration: CD4+ and CD8+ cells in orexin region
Complement activation: Possible effector mechanism

Clinical Features

Core Symptoms

Cataplexy

Cataplexy is pathognomonic for NT1:

Triggered by emotion: Especially laughter, surprise
Bilateral weakness: Often facial, neck, knees
Consciousness preserved: Patient aware but cannot move
Duration: Seconds to minutes
Mechanism: REM atonia circuit activation during wake

Disease Course

Onset: Typically adolescence/young adulthood (10-30 years)
Progression: Rapid loss over weeks to months
Stabilization: Symptoms stabilize after loss complete
Lifetime: Chronic condition, no disease modification

Neurodegeneration Relevance

Selective Vulnerability Model

NT1 provides insights into selective neuronal vulnerability:

Specific population: Only orexin neurons affected

Inflammatory trigger: Possible parallels in other diseases

Protein aggregation: Orexin may form aggregates

Clear boundary: Sharp distinction from normal tissue

Parkinson's Disease

Orexin loss: 30-60% reduction in PD
REM sleep behavior disorder: Shared pathology
Sleep fragmentation: Orexin dysfunction contributes
Motor symptoms: Orexin effects on basal ganglia

The orexin system is affected in PD, though less severely than in narcolepsy.[@fronczek2007]

Alzheimer's Disease

Orexin disruption: Altered orexin signaling in AD
Sleep-wake cycle disruption: Orexin dysregulation
Circadian disturbance: Orexin-SCN interactions
Neuroinflammation: Possible orexin neuron stress

Multiple System Atrophy

Severe orexin loss: >70% reduction reported
Hypothalamic involvement: Part of MSA pathology
Sleep disorders: Prominent orexin-related symptoms

Therapeutic Approaches

Symptomatic Treatment

Orexin Replacement

Intranasal orexin-A: Limited [blood-brain barrier](/entities/blood-brain-barrier) penetration
Small molecule OX2R agonist: Under development (TAK-994 discontinued)
Gene therapy: Preclinical orexin gene delivery
Cell transplantation: Stem cell-derived orexin neurons

Immunomodulation (Early Disease)

IVIG: Limited evidence, mixed results
Rituximab: B cell depletion, case reports
Plasmapheresis: Anecdotal reports
Timing critical: Must intervene before complete loss

Diagnostic Evaluation

CSF Orexin Measurement

Gold standard: CSF orexin-A <110 pg/mL
Specificity: >95% for NT1
Sensitivity: >95% for NT1 with cataplexy
Lumbar puncture required: Invasive procedure

Polysomnography and MSLT

Mean sleep latency: ≤8 minutes
SOREMPs: ≥2 within 20 minutes
REM sleep dysregulation: Frequent SOREMPs
Nighttime sleep fragmentation: Reduced efficiency

HLA Typing

DQB1*06:02: Present in >95% NT1, 20-30% general population
Limited specificity: Cannot diagnose alone
Risk stratification: Combined with symptoms

Future Directions

Disease Modification

Early detection: Pre-symptomatic orexin decline
Immunotherapy trials: Preventive intervention
Neuroprotection: Prevent orexin neuron loss
Regeneration: Stimulate orexin neurogenesis

Biomarker Development

Blood orexin: Less invasive measurement
PET imaging: Orexin neuron visualization
Autoantibody panels: Diagnosis and monitoring
Genetic risk scores: HLA + non-HLA variants

Novel Therapeutics

Selective OX2R agonists: Disease-specific target
Allosteric modulators: Fine-tuned receptor activation
Nasal delivery systems: Improved BBB penetration
Combination approaches: Symptomatic + disease-modifying

[/diseases/narcolepsy — Narcolepsy overview](/content/diseases)
[/brain-regions/lateral-hypothalamus — Orexin neuron location](/brain-regions/thalamus)
[/mechanisms/sleep-wake-regulation — Sleep circuitry](/content/mechanisms)
[/diseases/parkinsons-disease — PD orexin involvement](/content/diseases)
[/mechanisms/autoimmunity-neurodegeneration — Autoimmune mechanisms](/content/mechanisms)

📖 View canonical wiki page →

Related Entities

cell-types-orexin-neurons-narcolepsy-v2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-orexin-neurons-narcolepsy-v2
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-fe7aa31eb44f
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-orexin-neurons-narcolepsy-v2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

Outgoing

0 supporting 0 contradicting 0 neutral

View full evidence profile →

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

This artifact has no version history yet.

Linked Artifacts (61)

derives_from?Combination approaches90%

derives_from?Allosteric modulators90%

derives_from?Blood orexin90%

derives_from?Regeneration90%

derives_from?Selective OX2R agonists90%

derives_from?Neuroprotection90%

derives_from?Early detection90%

derives_from?PET imaging90%

derives_from?Autoantibody panels90%

derives_from?Nasal delivery systems90%

derives_from?Genetic risk scores90%

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

derives_from?Immunotherapy trials90%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

mentions🧪Orexin-Microglia Modulation Therapy50%

mentions🧪APOE-Dependent Autophagy Restoration50%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬Epigenetic reprogramming in aging neurons40%

mentions🔬What are the mechanisms underlying selective vulnerability o40%

mentions🔬Mitochondrial transfer between astrocytes and neurons40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

mentions🔬What are the mechanisms underlying mitochondrial transfer be40%

mentions🔬Why do entorhinal cortex layer II stellate neurons die first40%

Reference URLs

Canonical (singular)/artifact/wiki-cell-types-orexin-neurons-narcolepsy-v2canonical

Canonical (plural, REST)/artifacts/wiki-cell-types-orexin-neurons-narcolepsy-v2alias

API (JSON)/api/artifacts/wiki-cell-types-orexin-neurons-narcolepsy-v2api

Citation — BibTeX/artifacts/wiki-cell-types-orexin-neurons-narcolepsy-v2/cite?fmt=bibtexexport

Citation — RIS/artifacts/wiki-cell-types-orexin-neurons-narcolepsy-v2/cite?fmt=risexport

Citation — CSL-JSON/artifacts/wiki-cell-types-orexin-neurons-narcolepsy-v2/cite?fmt=cslexport

Embed this artifact

Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.

HTML iframe

<iframe src="http://scidex.ai/artifact/wiki-cell-types-orexin-neurons-narcolepsy-v2?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[Orexin Neurons in Narcolepsy with Cataplexy](http://scidex.ai/artifact/wiki-cell-types-orexin-neurons-narcolepsy-v2)

Direct URL

http://scidex.ai/artifact/wiki-cell-types-orexin-neurons-narcolepsy-v2

Preview

🔄 Adjacent Artifacts Recommended based on your interests

💬 Discussion

Loading comments...

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Orexin Neurons in Narcolepsy with Cataplexy

Orexin Neurons in Narcolepsy with Cataplexy

Introduction

Orexin Neurons in Narcolepsy with Cataplexy

Introduction

Neuroanatomy of Orexin Neurons

Location and Distribution

Morphology

Projection Targets

Molecular Biology

Orexin Peptides

Orexin Receptors

Intracellular Signaling

Transcriptional Regulation

Physiology of Wakefulness

Wake-Sleep Switch Model

Diurnal Rhythm

Metabolic Integration

Narcolepsy Pathophysiology

Selective Neuron Loss

Autoimmune Hypothesis

Molecular Mimicry

Neuroinflammation

Clinical Features

Core Symptoms

Cataplexy

Disease Course

Neurodegeneration Relevance

Selective Vulnerability Model

Parkinson's Disease

Alzheimer's Disease

Multiple System Atrophy

Therapeutic Approaches

Symptomatic Treatment

Orexin Replacement

Immunomodulation (Early Disease)

Diagnostic Evaluation

CSF Orexin Measurement

Polysomnography and MSLT

HLA Typing

Future Directions

Disease Modification

Biomarker Development

Novel Therapeutics

See Also

💬 Discussion